Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?

被引：0
|
作者：
Felicetto Ferrara
机构：
[1] Cardarelli Hospital,Division of Hematology
来源：
Blood Cancer Journal | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Venetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold?
    Ferrara, Felicetto
    [J]. BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [2] Venetoclax plus Cladribine plus Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax plus Hypomethylating Agent
    Steinauer, Nickolas
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Mangaonkar, Abhishek A.
    Saliba, Antoine
    Hefazi, Mehrdad
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Pardanani, Animesh D.
    Badar, Talha
    Murthy, Hemant S.
    Foran, James M.
    Yi, Cecilia Y. Arana
    Tefferi, Ayalew
    Gangat, Naseema
    [J]. BLOOD, 2023, 142
  • [3] Low-dose cytarabine and hypomethylating agents for Down syndrome with acute myeloid leukemia
    Ramakrishnan, Ramya
    Munir, Faryal
    Quesada, Andres Ernesto
    Hitzler, Johann
    Cuglievan, Branko
    [J]. PEDIATRIC BLOOD & CANCER, 2024, 71 (06)
  • [4] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
  • [5] Venetoclax with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting
    Piccini, Matteo
    Pilerci, Sofia
    Scappini, Barbara
    Bencini, Sara
    Peruzzi, Benedetta
    Caporale, Roberto
    Signori, Leonardo
    Fabiana, Pancani
    Maria, Vannucchi Alessandro
    Gianfaldoni, Giacomo
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S289 - S289
  • [6] Venetoclax in Combination with Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Single-Centre Experience
    Piccini, Matteo
    Pilerci, Sofia
    Scappini, Barbara
    Mannelli, Francesco
    Ciolli, Gaia
    Pasquini, Andrea
    Fasano, Laura
    Quinti, Elisa
    Guglielmelli, Paola
    Mannarelli, Carmela
    Pancani, Fabiana
    Zizza, Michela
    Signori, Leonardo
    Vannucchi, Alessandro M.
    Gianfaldoni, Giacomo
    [J]. BLOOD, 2022, 140 : 9008 - 9009
  • [7] Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?
    Pollyea, Daniel A.
    Jordan, Craig T.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2019, 26 (02) : 71 - 76
  • [8] Exposure-Response Analysis of Venetoclax in Combination with Hypomethylating Agents or Low-Dose Cytarabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
    Agarwal, Suresh
    Gopalakrishnan, Sathej
    Mensing, Sven
    Potluri, Jalaja
    Hayslip, John
    Friedel, Anna
    Menon, Rajeev
    Salem, Ahmed Hamed
    [J]. BLOOD, 2018, 132
  • [9] Safety and Efficacy of Venetoclax Combined with Hypomethylating Agents or Low-Dose Cytarabine for Acute Myeloid Leukemia before and after Allogeneic Hematopoietic Cell Transplantation
    Pessoa Mendes, Rafael Fernandes
    Fatobene, Giancarlo
    Molla, Vinicius
    Helman, Ricardo
    Rodrigues, Morgani
    Schmidt Filho, Jayr
    Novis, Yana
    Rodrigues, Celso Arrais
    Rocha, Vanderson
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S300 - S300
  • [10] Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia
    DiNardo, Courtney D.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 82 - 83
12345